General Information:

Id: 8,123
Diseases: Alzheimer disease - [OMIM]
Homo sapiens
review
Reference: Enche Ady CNA et al.(2017) Metabolomic-guided discovery of Alzheimers disease biomarkers from body fluid J. Neurosci. Res. 95: 2005-2024 [PMID: 28301062]

Interaction Information:

Comment The concentration cholesterol was increased in serum of Alzheimer disease (AD) patients compared to healthy controls.
Formal Description
Interaction-ID: 81465

disease

Alzheimer disease

increases_quantity of

drug/chemical compound

Cholesterol

in serum; measured by GC-MS (Spain)
Drugbank entries Show/Hide entries for
Comment The concentration oleic acid was increased in serum of Alzheimer disease (AD) patients compared to healthy controls.
Formal Description
Interaction-ID: 81478

disease

Alzheimer disease

increases_quantity of

drug/chemical compound

Oleic acid

in serum; measured by GC-MS (Spain)
Drugbank entries Show/Hide entries for
Comment The concentration palmitic acid was decreased in serum of Alzheimer disease (AD) patients compared to healthy controls.
Formal Description
Interaction-ID: 81480

disease

Alzheimer disease

decreases_quantity of

drug/chemical compound

Palmitic acid

in serum; measured by GC-MS (Spain)
Drugbank entries Show/Hide entries for
Comment The concentration stearic acid was decreased in serum of Alzheimer disease (AD) patients compared to healthy controls.
Formal Description
Interaction-ID: 81482

disease

Alzheimer disease

decreases_quantity of

drug/chemical compound

Stearic acid

in serum; measured by GC-MS (Spain)
Drugbank entries Show/Hide entries for
Comment The concentration cystine was decreased in serum of Alzheimer disease (AD) patients compared to healthy controls.
Formal Description
Interaction-ID: 81483

disease

Alzheimer disease

decreases_quantity of

drug/chemical compound

Cystine

in serum; measured by GC-MS (Spain)
Comment The concentration valine was decreased in serum of Alzheimer disease (AD) patients compared to healthy controls.
Formal Description
Interaction-ID: 81496

disease

Alzheimer disease

decreases_quantity of

drug/chemical compound

Valine

in serum; measured by GC-MS (Spain)
Comment The concentration tryptophan was decreased in serum of Alzheimer disease (AD) patients compared to heathy controls.
Formal Description
Interaction-ID: 81501

disease

Alzheimer disease

decreases_quantity of

drug/chemical compound

Tryptophan

in serum; measured by GC-MS (Spain)
Comment The concentration aspartic acid was decreased in serum of Alzheimer disease (AD) patients compared to healthy controls.
Formal Description
Interaction-ID: 81507

disease

Alzheimer disease

decreases_quantity of

drug/chemical compound

Aspartate

in serum; measured by GC-MS (Spain)
Comment The concentration pyroglutamic acid was decreased in serum of Alzheimer disease (AD) patients compared to healthy controls.
Formal Description
Interaction-ID: 81512

disease

Alzheimer disease

decreases_quantity of

drug/chemical compound

Pyroglutamate

in serum; measured by GC-MS (Spain)
Comment The concentration phenylalanine was decreased in serum of Alzheimer disease (AD) patients compared to healthy controls.
Formal Description
Interaction-ID: 81514

disease

Alzheimer disease

decreases_quantity of

drug/chemical compound

Phenylalanine

in serum; measured by GC-MS (Spain)
Comment The concentration glutamine was decreased in serum of Alzheimer disease (AD) patients compared to healthy controls.
Formal Description
Interaction-ID: 81516

disease

Alzheimer disease

decreases_quantity of

drug/chemical compound

Glutamine

in serum; measured by GC-MS (Spain)
Comment The concentration asparagine was decreased in serum of Alzheimer disease (AD) patients compared to healthy controls.
Formal Description
Interaction-ID: 81520

disease

Alzheimer disease

decreases_quantity of

drug/chemical compound

Asparagine

in serum; measured by GC-MS (Spain)
Comment The concentration ornithine was decreased in serum of Alzheimer disease (AD) patients compared to healthy controls.
Formal Description
Interaction-ID: 81522

disease

Alzheimer disease

decreases_quantity of

drug/chemical compound

Ornithine

in serum; measured by GC-MS (Spain)
Comment The concentration pipecolic acid was decreased in serum of Alzheimer disease (AD) patients compared to healthy controls.
Formal Description
Interaction-ID: 81527

disease

Alzheimer disease

decreases_quantity of

drug/chemical compound

Pipecolate

in serum; measured by GC-MS (Spain)
Comment The concentration histidine was decreased in serum of Alzheimer disease (AD) patients compared to healthy controls.
Formal Description
Interaction-ID: 81536

disease

Alzheimer disease

decreases_quantity of

drug/chemical compound

Histidine

in serum; measured by GC-MS (Spain)
Comment The concentration isocitric acid was increased in serum of Alzheimer disease (AD) patients compared to healthy controls.
Formal Description
Interaction-ID: 81538

disease

Alzheimer disease

increases_quantity of

drug/chemical compound

Isocitrate

in serum; measured by GC-MS (Spain)
Comment The concentration urea was increased in serum of Alzheimer disease (AD) patients compared to healthy controls.
Formal Description
Interaction-ID: 81540

disease

Alzheimer disease

decreases_quantity of

drug/chemical compound

Urea

in serum; measured by GC-MS (Spain)
Drugbank entries Show/Hide entries for Urea